NO965569L - Forbindelser og fremgangsmåter for behandling av kardiovaskulære, inflammatoriske og immunoforstyrrelser - Google Patents

Forbindelser og fremgangsmåter for behandling av kardiovaskulære, inflammatoriske og immunoforstyrrelser

Info

Publication number
NO965569L
NO965569L NO965569A NO965569A NO965569L NO 965569 L NO965569 L NO 965569L NO 965569 A NO965569 A NO 965569A NO 965569 A NO965569 A NO 965569A NO 965569 L NO965569 L NO 965569L
Authority
NO
Norway
Prior art keywords
lipoxygenase
compounds
inflammatory
activity
acting
Prior art date
Application number
NO965569A
Other languages
English (en)
Norwegian (no)
Other versions
NO965569D0 (no
Inventor
Xiong Cai
Gurmit Grewal
Sajjat Hussoin
Aberra Fura
Ralph Scannell
Tesfaye Biftu
Changgeng Qian
Original Assignee
Cytomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/265,656 external-priority patent/US5792776A/en
Priority claimed from US08/390,641 external-priority patent/US6201016B1/en
Priority claimed from US08/454,600 external-priority patent/US5750565A/en
Priority claimed from US08/454,748 external-priority patent/US5703093A/en
Application filed by Cytomed Inc filed Critical Cytomed Inc
Publication of NO965569D0 publication Critical patent/NO965569D0/no
Publication of NO965569L publication Critical patent/NO965569L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO965569A 1994-06-27 1996-12-23 Forbindelser og fremgangsmåter for behandling av kardiovaskulære, inflammatoriske og immunoforstyrrelser NO965569L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/265,656 US5792776A (en) 1994-06-27 1994-06-27 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US08/390,641 US6201016B1 (en) 1994-06-27 1995-02-17 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US08/454,600 US5750565A (en) 1995-05-25 1995-05-25 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US08/454,748 US5703093A (en) 1995-05-31 1995-05-31 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
PCT/US1995/008213 WO1996000212A1 (fr) 1994-06-27 1995-06-27 Composes et procedes pour le traitement des troubles cardio-vasculaires, inflammatoires et immunitaires

Publications (2)

Publication Number Publication Date
NO965569D0 NO965569D0 (no) 1996-12-23
NO965569L true NO965569L (no) 1997-02-17

Family

ID=27500861

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965569A NO965569L (no) 1994-06-27 1996-12-23 Forbindelser og fremgangsmåter for behandling av kardiovaskulære, inflammatoriske og immunoforstyrrelser

Country Status (17)

Country Link
EP (1) EP0770064B1 (fr)
KR (1) KR100276570B1 (fr)
CN (1) CN1151125C (fr)
AT (1) ATE253564T1 (fr)
AU (1) AU703756B2 (fr)
BR (1) BR9508196A (fr)
CA (1) CA2194064C (fr)
CZ (1) CZ372096A3 (fr)
DE (1) DE69532077T2 (fr)
EE (1) EE9600184A (fr)
FI (1) FI965123A7 (fr)
HU (1) HUT77773A (fr)
MX (1) MX9606635A (fr)
NO (1) NO965569L (fr)
PL (1) PL317873A1 (fr)
RU (1) RU2190607C2 (fr)
WO (1) WO1996000212A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
ATE196903T1 (de) 1992-07-13 2000-10-15 Cytomed Inc 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US6201016B1 (en) 1994-06-27 2001-03-13 Cytomed Incorporated Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
WO1999049865A1 (fr) * 1998-03-31 1999-10-07 Mayo Foundation For Medical Education And Research Utilisation d'inhibiteurs du facteur d'activation des plaquettes sanguines (paf) pour entraver une activation ou une degranulation eosinophilique declenchee par l'interleukine 5
CA2342156A1 (fr) 1998-07-03 2000-01-13 Andappan Murugaiah Subbaiah Murugaiah Procedes de synthese de compose de tetrahydrofuran substitue
JP2002519375A (ja) * 1998-07-03 2002-07-02 リューコサイト インク 酸素脂環化合物置換体、及びその合成法
US6255498B1 (en) 1998-10-16 2001-07-03 Millennium Pharmaceuticals, Inc. Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans
AU2001279313B2 (en) 2000-08-04 2007-03-01 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
ATE520981T1 (de) 2002-10-02 2011-09-15 Dmi Biosciences Inc Diagnose und überwachung von krankheiten
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
RU2217141C1 (ru) * 2002-11-20 2003-11-27 Балавадзе Михаил Элизбарович Состав "витализин-1" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний
SE0301010D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
CA3050734A1 (fr) 2003-05-15 2004-12-02 Ampio Pharmaceuticals, Inc. Traitement de maladies a mediation des lymphocytes t
NZ545314A (en) * 2003-08-04 2009-03-31 Bristol Myers Squibb Co Methods for treating cardiovascular disease using a soluble CTLA4 molecule
CA2554709C (fr) * 2004-01-30 2011-11-15 Schering Corporation Polymorphes cristallins d'un ligand du recepteur des cxc-chimiokines
WO2009146320A1 (fr) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Procédés et composés thérapeutiques
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
EP2766029B1 (fr) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Traitement de maladie dégénérative articulaire
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
CA2846394A1 (fr) 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Traitement de la rhinite
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
KR101503647B1 (ko) 2014-07-03 2015-03-18 주식회사 큐리언트 염증성 질환 치료용 약학적 조성물
KR101480674B1 (ko) * 2014-07-03 2015-01-09 주식회사 큐리언트 화합물 및 염증성 질환 치료용 약학적 조성물
KR101496095B1 (ko) * 2014-07-04 2015-03-03 주식회사 큐리언트 화합물 및 염증성 질환 치료용 약학적 조성물
KR101496094B1 (ko) 2014-07-04 2015-02-25 주식회사 큐리언트 화합물 및 염증성 질환 치료용 약학적 조성물
KR101496096B1 (ko) * 2014-07-17 2015-03-02 주식회사 큐리언트 화합물 및 염증성 질환 치료용 약학적 조성물
AU2015305611B2 (en) 2014-08-18 2020-04-23 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211146A (en) * 1984-02-29 1987-10-30 Merck & Co Inc 2,5-diaryl-tetrahydrothiophene derivatives and pharmaceutical compositions
US4757084A (en) * 1984-02-29 1988-07-12 Merck & Co., Inc. 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
DE3778248D1 (de) * 1986-08-21 1992-05-21 Merck & Co Inc 1,3-diarylcyclopentane und deren abkoemmlinge als paf-antagonisten.
US4873259A (en) * 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US4996203A (en) * 1987-12-21 1991-02-26 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
EP0365089A3 (fr) * 1988-10-18 1991-06-05 Merck & Co. Inc. 2-Aryl-5(3-méthoxy-5-(hydroxypropylsulphonyl)-4-propoxyphényl) tétrahydrothiophène et analogues
US5175183A (en) * 1989-02-01 1992-12-29 Abbott Laboratories Lipoxygenase inhibiting compounds
US4977146A (en) * 1989-06-08 1990-12-11 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5037853A (en) * 1989-12-28 1991-08-06 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
GB9009469D0 (en) * 1990-04-27 1990-06-20 British Bio Technology Compounds
CA2045863A1 (fr) * 1990-06-29 1991-12-30 Ichiro Shinkai Procede de fabrication de 2,5-diaryltetrahydrofuranes et de leurs analogues utilises comme antagonistes du paf
US5244896A (en) * 1990-09-14 1993-09-14 Marion Merrell Dow Inc. Carbocyclic adenosine analogs useful as immunosuppressants
US5110831A (en) * 1990-11-30 1992-05-05 Du Pont Merck Pharmaceutical Company Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors
JPH0730061B2 (ja) * 1991-02-07 1995-04-05 ファイザー製薬株式会社 ヒドロキサム酸誘導体および組成物
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
US5183818A (en) * 1991-08-27 1993-02-02 Abbott Laboratories Arylalkylether and arylalkylthioether inhibitors of lipoxygenase enzyme activity
US5169854A (en) * 1992-02-26 1992-12-08 Abbott Laboratories N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity
US5187192A (en) * 1992-03-13 1993-02-16 Abbott Laboratories Cyclobutyl derivatives having lipoxygenase inhibitory activity
US5326787A (en) * 1992-05-12 1994-07-05 Abbott Laboratories Cycloalkyl N-hydroxy derivatives having lipoxygenase inhibitory activity
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
ATE196903T1 (de) * 1992-07-13 2000-10-15 Cytomed Inc 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten
US5288751A (en) * 1992-11-06 1994-02-22 Abbott Laboratories [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis
TW448144B (en) * 1993-08-19 2001-08-01 Pfizer Phenoxyphenyl cyclopentenyl hydroxyureas

Also Published As

Publication number Publication date
HUT77773A (hu) 1998-08-28
HU9603611D0 (en) 1997-02-28
EP0770064B1 (fr) 2003-11-05
HK1004396A1 (en) 1998-11-27
EP0770064A1 (fr) 1997-05-02
DE69532077D1 (de) 2003-12-11
DE69532077T2 (de) 2004-09-02
ATE253564T1 (de) 2003-11-15
CN1151125C (zh) 2004-05-26
EE9600184A (et) 1997-06-16
AU2914295A (en) 1996-01-19
FI965123A0 (fi) 1996-12-19
CZ372096A3 (cs) 1998-04-15
CN1163610A (zh) 1997-10-29
WO1996000212A1 (fr) 1996-01-04
KR100276570B1 (ko) 2001-02-01
BR9508196A (pt) 1997-09-02
FI965123A7 (fi) 1997-02-26
PL317873A1 (en) 1997-04-28
EP0770064A4 (fr) 1998-01-14
CA2194064C (fr) 2009-03-17
MX9606635A (es) 1997-12-31
RU2190607C2 (ru) 2002-10-10
CA2194064A1 (fr) 1996-01-04
AU703756B2 (en) 1999-04-01
NO965569D0 (no) 1996-12-23

Similar Documents

Publication Publication Date Title
NO965569D0 (no) Forbindelser og fremgangsmåter for behandling av kardiovaskulære, inflammatoriske og immune forstyrrelser
EP0766676A4 (fr) Composes et procede destines a inhiber la phosphodiesterase iv
DE60315233D1 (de) Korrektur des asymmetrischen nahen Übersprechens veursacht durch die Übersprechkompensation der anderen Paare
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
NO20060719L (no) Substituerte cykloalkylaminderivater som modulatorer av kemokin reseptor aktivitet
BR9808998A (pt) Imidazóis substituìdos úteis no tratamento de doenças inflamatórias
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
HUP0001539A2 (hu) 2-(1-Imino-etil-amino)-etil-homocisztein, eljárás előállítására és az ezt tartalmazó gyógyszerkészítmények
FI971489A0 (fi) Uusia bentsoksatsoleja
FI20105844L (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
WO1993000330A3 (fr) Derives d'azanorbornane
DK1638551T3 (da) Immunosuppressive forbindelser og sammensætninger
NO20051036L (no) 3,4-disubstituerte syklobuten-1,2-dioner som CXC-kjemokinreseptorligander
SE9800836D0 (sv) New Compounds
MY150088A (en) Immunosuppressant compounds and compositions
NO970161L (no) Triazolforbindelser og anvendelse derav
EA200100958A1 (ru) Производные 4,5-диарил-3(2h)-фуранона как ингибиторы циклооксигеназы-2
CA2234642A1 (fr) 3,4-diaryle-2-hydroxy-2,5-dihydrofurans utilises comme promedicaments pour inhibiteurs de cox-2
AU1996301A (en) Novel heteroaryl-diazabicycloalkanes
AR019671A1 (es) Uso de una cantidad terapeuticamente efectiva de (+) norcisaprida o una sal farmacologicamente aceptable de la misma sustancialmente libre de su (-)estereoisomero, para la preparacion de un medicamento
WO2001035950A3 (fr) Agent therapeutique a base d'amide et procedes de traitement des affections intestinales inflammatoires
MA26779A1 (fr) Derives de 1-arenesulfonyl-2-aryl-pyrrolidine et de piperidine pour le traitement de troubles du systeme nerveux central.
ES2087038A1 (es) Nuevas piperidinas con actividad antagonista del paf.
GR3035063T3 (en) 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders.
ATE259804T1 (de) 8-azabicyclo(3.2.1)okt-2-en- und -oktanderivate